Abstract
Atenolol reduces QT dispersion and corrected QT interval in patients with syndrome X. This suggests that symptomatic improvement induced by atenolol in syndrome X patients may be partly related to reduction in abnormally augmented sympathetic tone.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have